24 articles for SE Webber
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.

Anadys Pharmaceuticals
Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.

Pfizer
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors.

University of Newcastle
Tricyclic benzimidazoles as potent poly(ADP-ribose) polymerase-1 inhibitors.

Pfizer
Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.

Pfizer
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.

Agouron Pharmaceuticals
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.

Agouron Pharmaceuticals
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements.

Agouron Pharmaceuticals
Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.

Agouron Pharmaceuticals
Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease.

Agouron Pharmaceuticals
Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones.

Agouron Pharmaceuticals
Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

Effector Therapeutics
Perspectives on SARS-CoV-2 Main Protease Inhibitors.

Michigan State University
Disubstituted compounds for treatment of medical disorders

Achillion Pharmaceuticals
Substituted 7-azabicycles and their use as orexin receptor modulators

Janssen Pharmaceutica
Substituted pyrrolopyrimidines as HDM2 inhibitors

Merck Sharp & Dohme
Heterocyclic compounds as inhibitors of class I PI3KS

TBA
Purinone compounds as kinase inhibitors

Pharmacyclics
Btk inhibitors

Merck Sharp & Dohme
Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof

Shanghai Hengrui Pharmaceutical
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors

Merck Sharp & Dohme
Amide or urea containing benzothiazole inhibitors of endothelial lipase

Bristol-Myers Squibb
Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones.

Birla Institute of Technology